Search For "pharma"
Hindustan Unilever completes acquisition of VWash from Glenmark Pharma
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 26 (ANI): Fast-moving consumer goods major Hindustan Unilever Ltd (HUL) said on Friday it has completed the acquisition of intimate hygiene brand VWash from Glenmark Pharmaceuticals.
Read More
India's trade deficit with China totalled $48.6 billion in FY20: Motilal O
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 25 (ANI): India's trade deficit with China more than doubled from 20 billion dollars in FY10 to 48.6 billion dollars in FY20, implying massive surge in dependence on Chinese products, Motilal Oswal Financial Services said on Thursday.
Read More
Maharashtra threatens action against Patanjali, says its anti-Corona drugs
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 25 (ANI): Maharashtra Home Minister Anil Deshmukh on Thursday said that legal action will be initiated against pharmaceutical giant Patanjali if there was any advertisement or sale of its newly-launched COVID-19 ayurvedic drugs 'Coronil and Swasari' in the
Read More
West Coast Pharmaceuticals launches SteriAll Vegetables And Fruits Wash
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], June 25 (ANI/NewsVoir): West Coast Pharmaceuticals - one of the leading pharmaceuticals company in India has launched SteriAll Vegetables and Fruits Wash with 100 per cent natural ingredients that ensures washing away 99.9 per cent germs, harmful pesticides, chem
Read More
COVID-19: States being delivered generic version of Remdesivir, 20 thousan
Updated : 5 years, 8 months ago IST
New Delhi [India], June 25 (ANI): Domestic pharma giant Hetero has started delivering the generic version of 20,000 vials of Covifor (Remdesivir) across the country. The product is priced at Rs 5,400/- per vial.
Read More
Ayush Ministry will clear stance on Patanjali's COVID-19 medicines after r
Updated : 5 years, 8 months ago IST
New Delhi [India], June 24 (ANI): MoS for the Union Ayush Ministry Shripad Naik on Wednesday said that his Ministry will clear its stance on pharmaceutical giant Patanjali's newly-launched ayurvedic drugs 'Coronil and Swasari' for the novel coronavirus after reviewing the report sent by i
Read More
NIPER comes up with immunity booster Herbal Tea
Updated : 5 years, 8 months ago IST
New Delhi [India], June 23 (ANI): National Institutes of Pharmaceutical Education and Research (NIPERs) come up with an immunity booster Herbal Tea to strengthen physical resistance to coronavirus infection.
Read More
Sensex closes 180 points up, Glenmark Pharma jumps 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices wiped out early gains but closed over half a per cent higher on Monday led by gains in banking, pharma and metal stocks.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Biocon, DKSH collaborate to commercialise 7 generic formulations in SE Asi
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], June 22 (ANI): Biopharmaceutical major Biocon Ltd and Swiss market expansion services group Diethelm Keller Siber Hegner (DKSH) said on Monday their subsidiaries have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic
Read More
Equity indices trade higher as banking, pharma stocks rally
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices rose by nearly 1 per cent during early hours on Monday led by gains in banking, pharma and metal stocks.
Read More
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell
Updated : 5 years, 9 months ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More